CLINTON GROUP INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
CLINTON GROUP INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$380,000
-9.5%
41,268
+15.9%
0.02%
+10.0%
Q3 2016$420,000
+86.7%
35,608
+105.0%
0.02%
+100.0%
Q2 2016$225,00017,3680.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders